Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 22026339)

1.

Management of pediatric tumor lysis syndrome.

Tazi I, Nafl H, Elhoudzi J, Mahmal L, Harif M.

Arab J Nephrol Transplant. 2011 Sep;4(3):147-54. Review.

2.

Tumor lysis syndrome: new challenges and recent advances.

Wilson FP, Berns JS.

Adv Chronic Kidney Dis. 2014 Jan;21(1):18-26. doi: 10.1053/j.ackd.2013.07.001. Review.

3.

[Tumor lysis syndrome in intensive therapy: diagnostic and therapeutic encare].

Burghi G, Berrutti D, Manzanares W.

Med Intensiva. 2011 Apr;35(3):170-8. doi: 10.1016/j.medin.2010.07.014. Epub 2010 Nov 26. Review. Spanish.

4.

Clarifying the role of rasburicase in tumor lysis syndrome.

Sood AR, Burry LD, Cheng DK.

Pharmacotherapy. 2007 Jan;27(1):111-21. Review.

PMID:
17192165
5.

The management of tumor lysis syndrome.

Rampello E, Fricia T, Malaguarnera M.

Nat Clin Pract Oncol. 2006 Aug;3(8):438-47. Review.

PMID:
16894389
6.

Management of pediatric tumor lysis syndrome in the emergency department.

Zonfrillo MR.

Emerg Med Clin North Am. 2009 Aug;27(3):497-504. doi: 10.1016/j.emc.2009.04.010.

PMID:
19646650
7.

Tumor lysis syndrome.

Jeha S.

Semin Hematol. 2001 Oct;38(4 Suppl 10):4-8. Review.

PMID:
11694945
8.

Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.

Kennedy LD, Ajiboye VO.

J Oncol Pharm Pract. 2010 Sep;16(3):205-13. doi: 10.1177/1078155209348719. Epub 2009 Nov 18. Review.

PMID:
19923162
9.

Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma.

Bercovitz RS, Greffe BS, Hunger SP.

Curr Opin Pediatr. 2010 Feb;22(1):113-6. doi: 10.1097/MOP.0b013e32833499e5.

PMID:
19926992
10.

Rasburicase in the prevention and treatment of tumour lysis syndrome.

Mayne N, Keady S, Thacker M.

Intensive Crit Care Nurs. 2008 Feb;24(1):59-62. Epub 2007 Aug 14. Review.

PMID:
17698360
11.

Incidence and pathogenesis of tumor lysis syndrome.

Locatelli F, Rossi F.

Contrib Nephrol. 2005;147:61-8. Review.

PMID:
15604606
12.

[Acute renal failure in patients with tumor lysis syndrome].

Nabeshima K, Saito S, Suzuki Y.

Nihon Rinsho. 2004 May;62 Suppl 5:486-90. Review. Japanese. No abstract available.

PMID:
15197969
13.

Management of hyperuricemia with rasburicase review.

de Bont JM, Pieters R.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1431-40. Review.

PMID:
15571272
14.

Rasburicase in cancer-related hyperuricemia.

Rodriguez M, Campara M, Haaf C.

Drugs Today (Barc). 2011 Aug;47(8):591-603. doi: 10.1358/dot.2011.47.8.1622067.

PMID:
21850282
15.

Rasburicase for the treatment of tumor lysis in hematological malignancies.

Malaguarnera G, Giordano M, Malaguarnera M.

Expert Rev Hematol. 2012 Feb;5(1):27-38. doi: 10.1586/ehm.11.73. Review.

PMID:
22272702
16.

Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.

Baeksgaard L, Sørensen JB.

Cancer Chemother Pharmacol. 2003 Mar;51(3):187-92. Epub 2003 Feb 28.

PMID:
12655435
17.
18.

Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management.

Abu-Alfa AK, Younes A.

Am J Kidney Dis. 2010 May;55(5 Suppl 3):S1-13; quiz S14-9. doi: 10.1053/j.ajkd.2009.10.056. Review.

PMID:
20420966
19.

Our experience with tumor lysis syndrome treatment.

Sirelkhatim A, Sejnova D, Puskacova J, Subova Z, Kaiserova E.

Bratisl Lek Listy. 2008;109(12):560-3.

PMID:
19348378
20.

How to prevent and manage tumor lysis syndrome.

Held-Warmkessel J.

Nursing. 2010 Feb;40(2):26-31; quiz 31-2. doi: 10.1097/01.NURSE.0000367861.28564.32. No abstract available.

PMID:
20083976
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk